|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 35/17 | |||
| C07K 14/725 | |||
| C07K 14/705 | |||
| C07K 19/00 | |||
| A61P 35/00 |
| (11) | Number of the document | 3186280 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15760045.3 |
| Date of filing the European patent application | 2015-08-28 | |
| (97) | Date of publication of the European application | 2017-07-05 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/047606 |
| Date | 2015-08-28 |
| (87) | Number | WO 2016/033570 |
| Date | 2016-03-03 |
| (30) | Number | Date | Country code |
| 201462043273 P | 2014-08-28 | US | |
| 201462078942 P | 2014-11-12 | US |
| (72) |
CHEN, Yan, US
SHAMAH, Steve, US
PAZMANY, Csaba, US
DUTTA-SIMMONS, Jui, US
|
| (73) |
Juno Therapeutics, Inc.,
400 Dexter Avenue North, Suite 1200, Seattle, WA 98109,
US
|
| (54) | ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR CD19 |
| ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR CD19 |